Company intelligence / Profile preview

Biocomp Research Institute

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

Clinical results published and anecdotal reports suggest that HEG neurofeedback can improve cognitive and psychological symptoms, with applications in anxiety, OCD, mild TBI and other brain health disorders. Peer-reviewed studies and clinical references are cited on their website but depth of clinical trial evidence is limited.

Therapeutic areas: NeurologyPsychiatry
Modalities: DeviceNon-pharmacological therapymHealth/medtech platform
Industry: Digital Health Medical Devices

Partnerships

Clinical collaborations with Matrix Lab BiofeedbackYork Biofeedback Centre

Beyond the preview

Go deeper on Biocomp Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biocomp Research Institute.

Explore the full profile